Evidence map›Paper›PMID 22114491›Full record

ArticleInternational journal of nanomedicine2011

Influence of surface charge on the potential toxicity of PLGA nanoparticles towards Calu-3 cells.

Simona Mura, Herve Hillaireau, Julien Nicolas, Benjamin Le Droumaguet, Claire Gueutin, Sandrine Zanna, Nicolas Tsapis, Elias Fattal

Abstract read
In one paragraph

Article in International journal of nanomedicine, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 46 papers.

0numbers the graph read from it
0cells of the map it votes in
46citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

46 citing papers in PubMed.

  1. Trial
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Review
  10. Article
  11. Article
  12. Article
  13. PLGA-Based Composites for Various Biomedical Applications.International journal of molecular sciences · 2022
    Review
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Simona MuraUniv Paris-Sud, UMR 8612, Châtenay Malabry, F-92296, France.
Herve Hillaireau
Julien Nicolas
Benjamin Le Droumaguet
Claire Gueutin
Sandrine Zanna
Nicolas Tsapis
Elias Fattal

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundBecause of the described hazards related to inhalation of manufactured nanoparticles, we investigated the lung toxicity of biodegradable poly (lactide-co-glycolide) (PLGA) nanoparticles displaying various surface properties on human bronchial Calu-3 cells.

methodsPositively and negatively charged as well as neutral nanoparticles were tailored by coating their surface with chitosan, Poloxamer, or poly (vinyl alcohol), respectively. Nanoparticles were characterized in terms of size, zeta potential, and surface chemical composition, confirming modifications provided by hydrophilic polymers.

resultsAlthough nanoparticle internalization by lung cells was clearly demonstrated, the cytotoxicity of the nanoparticles was very limited, with an absence of inflammatory response, regardless of the surface properties of the PLGA nanoparticles.

conclusionThese in vitro results highlight the safety of biodegradable PLGA nanoparticles in the bronchial epithelium and provide initial data on their potential effects and the risks associated with their use as nanomedicines.

Indexed as

BronchiCell LineCell SurvivalChitosanHumansInterleukin-6Interleukin-8Lactic AcidMicroscopy, ConfocalNanoparticlesPoloxamerPolyglycolic AcidPolylactic Acid-Polyglycolic Acid CopolymerPolyvinyl AlcoholRhodaminesStatic ElectricityChitosanInterleukin-6Interleukin-8Lactic AcidPoloxamerPolyglycolic AcidPolylactic Acid-Polyglycolic Acid CopolymerPolyvinyl Alcoholrhodamine BRhodaminesCalu-3inflammationnanoparticlesPLGAsurface propertiestoxicity

Identifiers

PMID22114491
PMCPMC3218574

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.